Virility Medical Ltd., founded in 2016 in Israel, sells the in2 device, an FDA-cleared wearable for premature ejaculation.
Virility Medical Ltd. sells the in2 device, a clinically proven, FDA-cleared wearable that uses muscle stimulation to help users contract their pelvic-floor muscles and delay ejaculation without medication. The device is sold directly to consumers through the company's online store in the United States and Israel. Established in 2016 in Israel, the company raised USD 10.00 mn in a Series C round in July 2022 from Migdal Insurance Company and Arkin Holdings.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in